Virtual reality goggles could revolutionize MS mobility tests
NCT ID NCT07361965
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test whether mixed reality (using Meta Quest 3 goggles) can reliably measure walking, standing, and balance in 75 people with multiple sclerosis. Participants will perform standard mobility tests both conventionally and in a mixed reality environment. The goal is to see if the digital version is as accurate and useful as traditional methods, potentially paving the way for remote assessments.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mixed reality-based functional mobility tests using Meta Quest 3
- What this could lead to
- If successful, this could provide a more objective and engaging way to assess mobility in MS, potentially enabling remote monitoring.
- What could go wrong
- This is a small, early-stage validity study, not a treatment trial. The technology may not prove reliable or practical for widespread use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Feb 2026
An estimate. Start dates often move.
- Expected to finish
-
Jul 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Individuals with MS who applied to the Selçuk University Faculty of Medicine Hospital MS Living Center
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * A confirmed diagnosis of multiple sclerosis (MS) established by a neurologist, * Not being in a relapse phase and having no MS relapse within the past 6 months, * Aged between 18 and 60 years, * Disease severity within an Expanded Disability Status Scale (EDSS) range of 1-5 (mild to moderate functional impairment), * Visual, auditory, and vestibular functions sufficient to tolerate mixed reality-based applications, * Adequate cognitive capacity to actively participate in the study (e.g., Mini-Mental State Examination score ≥ 24), * Ability to read, understand, and follow instructions in Turkish, * Willingness to participate voluntarily in the study and provision of written informed consent. Exclusion Criteria: * Having experienced a multiple sclerosis relapse or undergone a change in MS-related treatment within the past 6 months, * Presence of severe musculoskeletal disorders (e.g., fracture, arthritis, advanced osteoarthritis, muscle tear) that may interfere with test performance, * Presence of severe cardiopulmonary disease (e.g., uncontrolled hypertension, heart failure, chronic obstructive pulmonary disease) or any medical condition that may pose a risk during exercise testing, * Risk of loss of balance or spatial disorientation in the mixed reality environment due to visual, vestibular, or auditory impairments, * Inability to perform functional tests due to severe spasticity, contractures, or orthopedic deformities, * History of epilepsy, migraine, or other neurological conditions that contraindicate the use of mixed reality or virtual reality devices, * Inability to understand test instructions due to cognitive impairment or severe mental health disorders (e.g., dementia, major depression, psychotic disorders), * Experiencing dizziness, nausea, or virtual reality-related symptoms (VR sickness) during testing, * Insufficient motivation or poor compliance that may hinder participation in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Mixed reality are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Selcuk University Faculty of Medicine Hospital MS Life Center
Konya, Selcuklu, 42130, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simulator-Based assessment of driving performance in patients with Parkinson's disease and multiple sclerosis
- Contrasting chronic inflammation and neurodegeneration using the human amniotic mesenchymal cell secretome as an innovative therapeutic strategy
- VIGIP-SEP2: evaluation of the impact of the training of patients by nurses on the adverse drug reaction reporting by RRMS patient via a mobile application: a randomized real-life study
- Five-second sprints on a bike: a new test for multiple sclerosis symptoms
- A new way to gauge balance training intensity in MS?
- A PET tracer aims to reveal the brain inflammation MRI misses in MS